Atrial Fibrillation Ablation in Patients With Therapeutic International Normalized Ratio
Oussama M. Wazni(Cleveland Clinic), Andrea Natale(Texas Cardiac Arrhythmia), Walid I. Saliba(Cleveland Clinic), Conor D. Barrett(Massachusetts General Hospital), Mohamed Kanj(Cleveland Research (United States)), Jennifer E. Cummings(Cleveland Clinic), David O. Martin(Cleveland Clinic), Salwa Beheiry(Texas Cardiac Arrhythmia), Dimpi Patel(Texas Cardiac Arrhythmia), Robert A. Schweikert(Texas Cardiac Arrhythmia), Steven Hao(Texas Cardiac Arrhythmia), Luigi Di Biase(Albert Einstein College of Medicine), Mauricio Arruda(Cleveland Research (United States)), Tamer S. Fahmy(Cairo University)
Cited by 251
Related Papers
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|Heart Rhythm|2017|2.7k
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation
|EP Europace|2017|1.2k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device
|Circulation|2016|855
Does the Left Atrial Appendage Morphology Correlate With the Risk of Stroke in Patients With Atrial Fibrillation?
|Journal of the American College of Cardiology|2012|834